FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200445707> ?p ?o ?g. }

• W4200445707 endingPage "179" @default.
• W4200445707 startingPage "171" @default.
• W4200445707 abstract "Analyze the pattern of disease failure after anti-CD19-directed chimeric antigen receptor T-cell therapy (CART) for non-Hodgkin lymphoma, assess the local control rate of bridging radiotherapy (bRT) and characterize in-field recurrences.We retrospectively reviewed 120 patients with NHL who received CART between 2018 and 2020. Baseline characteristics and treatment outcomes were compared between patients who received bRT and those who did not (noRT).Of the 118 patients included, 14 (12%) received bRT, while 104 (88%) did not. bRT group had more localized and extranodal disease. bRT was delivered with a median dose of 20 Gy (range: 15-36) in 5 fractions (range: 3-24). Pattern of failure analysis revealed that progression involving pre-existing sites was the predominant pattern of failure in both the bRT and noRT groups (86% and 88%, respectively). Median duration of response was 128 days (range: 25-547) for bRT group and 93 days (range: 22-965) for noRT group (p = 0.78). In the bRT group, only 2/15 sites irradiated had infield recurrence and where characterized by bulky disease, SUVmax >20, elevated LDH at the time of CART infusion, and extranodal involvement. The bRT 1-year LC was 86%. Median duration of local response was 257 days (range: 25-630) for radiation-bridged sites.Majority of progressions after CART infusion involve pre-existing sites. Bridging RT prior to CART provides excellent in-field local control and durable response. Patients with bulky disease, SUVmax >20, elevated LDH, and extranodal involvement are likely at higher risk of in-field recurrence after bRT and may benefit from higher curative doses of bRT." @default.
• W4200445707 created "2021-12-31" @default.
• W4200445707 creator A5004386819 @default.
• W4200445707 creator A5008583422 @default.
• W4200445707 creator A5009318345 @default.
• W4200445707 creator A5013192671 @default.
• W4200445707 creator A5017327825 @default.
• W4200445707 creator A5023100809 @default.
• W4200445707 creator A5023628069 @default.
• W4200445707 creator A5026397451 @default.
• W4200445707 creator A5033395766 @default.
• W4200445707 creator A5038008601 @default.
• W4200445707 creator A5051399808 @default.
• W4200445707 creator A5056239333 @default.
• W4200445707 creator A5059729547 @default.
• W4200445707 creator A5061845933 @default.
• W4200445707 creator A5062341100 @default.
• W4200445707 creator A5069952110 @default.
• W4200445707 creator A5075456418 @default.
• W4200445707 creator A5076892547 @default.
• W4200445707 creator A5078705257 @default.
• W4200445707 creator A5081655908 @default.
• W4200445707 creator A5082128548 @default.
• W4200445707 creator A5083513023 @default.
• W4200445707 creator A5089032046 @default.
• W4200445707 creator A5090442154 @default.
• W4200445707 creator A5090694142 @default.
• W4200445707 date "2022-01-01" @default.
• W4200445707 modified "2023-10-05" @default.
• W4200445707 title "Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?" @default.
• W4200445707 cites W1977364845 @default.
• W4200445707 cites W1995981720 @default.
• W4200445707 cites W2023809901 @default.
• W4200445707 cites W2059287651 @default.
• W4200445707 cites W2080958912 @default.
• W4200445707 cites W2104187048 @default.
• W4200445707 cites W2118796952 @default.
• W4200445707 cites W2119147717 @default.
• W4200445707 cites W2124373740 @default.
• W4200445707 cites W2129702476 @default.
• W4200445707 cites W2144329058 @default.
• W4200445707 cites W2170513194 @default.
• W4200445707 cites W2509364267 @default.
• W4200445707 cites W2766567226 @default.
• W4200445707 cites W2771352624 @default.
• W4200445707 cites W2773804840 @default.
• W4200445707 cites W2775369717 @default.
• W4200445707 cites W2790373585 @default.
• W4200445707 cites W2889673537 @default.
• W4200445707 cites W2897903823 @default.
• W4200445707 cites W2903062212 @default.
• W4200445707 cites W2903225254 @default.
• W4200445707 cites W2905654445 @default.
• W4200445707 cites W2946366893 @default.
• W4200445707 cites W2952960709 @default.
• W4200445707 cites W2954869918 @default.
• W4200445707 cites W2975698546 @default.
• W4200445707 cites W2982142006 @default.
• W4200445707 cites W3026897105 @default.
• W4200445707 cites W3033787987 @default.
• W4200445707 cites W3037322433 @default.
• W4200445707 cites W3082855561 @default.
• W4200445707 cites W3179559390 @default.
• W4200445707 doi "https://doi.org/10.1016/j.radonc.2021.11.031" @default.
• W4200445707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34890736" @default.
• W4200445707 hasPublicationYear "2022" @default.
• W4200445707 type Work @default.
• W4200445707 citedByCount "19" @default.
• W4200445707 countsByYear W42004457072022 @default.
• W4200445707 countsByYear W42004457072023 @default.
• W4200445707 crossrefType "journal-article" @default.
• W4200445707 hasAuthorship W4200445707A5004386819 @default.
• W4200445707 hasAuthorship W4200445707A5008583422 @default.
• W4200445707 hasAuthorship W4200445707A5009318345 @default.
• W4200445707 hasAuthorship W4200445707A5013192671 @default.
• W4200445707 hasAuthorship W4200445707A5017327825 @default.
• W4200445707 hasAuthorship W4200445707A5023100809 @default.
• W4200445707 hasAuthorship W4200445707A5023628069 @default.
• W4200445707 hasAuthorship W4200445707A5026397451 @default.
• W4200445707 hasAuthorship W4200445707A5033395766 @default.
• W4200445707 hasAuthorship W4200445707A5038008601 @default.
• W4200445707 hasAuthorship W4200445707A5051399808 @default.
• W4200445707 hasAuthorship W4200445707A5056239333 @default.
• W4200445707 hasAuthorship W4200445707A5059729547 @default.
• W4200445707 hasAuthorship W4200445707A5061845933 @default.
• W4200445707 hasAuthorship W4200445707A5062341100 @default.
• W4200445707 hasAuthorship W4200445707A5069952110 @default.
• W4200445707 hasAuthorship W4200445707A5075456418 @default.
• W4200445707 hasAuthorship W4200445707A5076892547 @default.
• W4200445707 hasAuthorship W4200445707A5078705257 @default.
• W4200445707 hasAuthorship W4200445707A5081655908 @default.
• W4200445707 hasAuthorship W4200445707A5082128548 @default.
• W4200445707 hasAuthorship W4200445707A5083513023 @default.
• W4200445707 hasAuthorship W4200445707A5089032046 @default.
• W4200445707 hasAuthorship W4200445707A5090442154 @default.
• W4200445707 hasAuthorship W4200445707A5090694142 @default.
• W4200445707 hasBestOaLocation W42004457071 @default.
• W4200445707 hasConcept C126322002 @default.

• next